Victrex Revenue 2019-2025 | VTXPF
Victrex revenue from 2019 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Victrex Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $382 |
| 2024 | $369 |
| 2023 | $377 |
| 2022 | $437 |
| 2021 | $419 |
| 2020 | $339 |
| 2019 | $375 |
| 2018 | $439 |
| 2016 | $359 |
| 2015 | $407 |
| 2014 | $418 |
|
Victrex Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | |
| 2025-03-31 | |
| 2024-09-30 | |
| 2024-03-31 | |
| 2023-09-30 | |
| 2023-03-31 | |
| 2022-09-30 | |
| 2022-03-31 | |
| 2021-09-30 | |
| 2021-03-31 | |
| 2020-09-30 | |
| 2020-03-31 | |
| 2019-09-30 | |
| 2019-03-31 | |
| 2018-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Basic Materials | Chemicals - Plastics | $0.674B | $0.382B |
| Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Covestro AG (COVTY) | Germany | $14.306B | 0.00 |
| Kuraray (KURRY) | Japan | $3.353B | 13.39 |
| Lightwave Logic (LWLG) | United States | $1.578B | 0.00 |
| Tredegar (TG) | United States | $0.307B | 12.11 |